01 / 21

Disease After 1900
Advances & Limitations

Explore how technological breakthroughs transformed the global fight against disease, and why persistent inequalities limited their reach across the 20th and 21st centuries.

AP World History

Why Disease History Matters

The 20th century saw humanity's most dramatic victories against infectious disease: antibiotics, vaccines, and public health infrastructure saved hundreds of millions of lives. Yet these same advances revealed deep global inequalities that persist today.

Key Terms to Know

Pandemic
A disease outbreak that spreads across multiple countries or continents, affecting large populations simultaneously.
Epidemiological Transition
The shift from infectious diseases to chronic diseases as the leading causes of death, driven by modernization.
Green Revolution
Agricultural advances that improved nutrition and indirectly reduced disease vulnerability in developing nations.

A Century of Breakthroughs

1918
Spanish Influenza
Killed 50-100 million people; exposed limits of early 20th-century medicine
1928
Penicillin Discovered
Alexander Fleming's accidental discovery launched the antibiotic revolution
1955
Polio Vaccine
Jonas Salk's vaccine began the near-eradication of poliomyelitis
1980
Smallpox Eradicated
WHO declared smallpox the first disease eliminated by human effort
1981
HIV/AIDS Identified
New pandemic revealed persistent vulnerabilities despite medical progress
2020
COVID-19 & mRNA Vaccines
Fastest vaccine development in history; global distribution remained unequal

Major Technological Advances

1
Antibiotics (1928+): Penicillin and subsequent drugs transformed bacterial infections from death sentences into treatable conditions.
2
Vaccines (1950s+): Mass vaccination campaigns against polio, measles, and smallpox saved hundreds of millions of lives globally.
3
Public Health Infrastructure: Clean water systems, sanitation, and disease surveillance became standard in industrialized nations.
4
Antiretroviral Therapy (1990s+): Transformed HIV/AIDS from a fatal diagnosis into a manageable chronic condition.

Persistent Limitations

1
Unequal Access: Lifesaving treatments often reached wealthy nations decades before developing countries could afford or distribute them.
2
Antibiotic Resistance: Overuse and misuse of antibiotics created "superbugs" that resist treatment, a growing crisis by the 21st century.
3
New Pandemics: HIV/AIDS, SARS, Ebola, and COVID-19 showed that new diseases continually emerge faster than treatments can be developed.
4
Political & Economic Barriers: Cold War rivalries, patent laws, and poverty prevented global cooperation on disease prevention.

The Epidemiological Transition

Share of Deaths (%) 1900 1930 1960 1990 2020 0 20 40 60 80 Infectious Diseases Chronic Diseases Crossover ~1960s

Global North vs. Global South

Global North
Completed epidemiological transition by mid-century. Chronic diseases dominate. Universal healthcare systems expanded access to treatment.
Global South
Faces a "double burden": infectious diseases persist alongside rising chronic diseases. Limited infrastructure, drug patents, and poverty restrict access.

How to Analyze AP Questions

1
Identify the Technology: What specific advance is being discussed? (Antibiotics, vaccines, sanitation, etc.)
2
Note the Region: Is the question about industrialized nations or the developing world? The answer often depends on this distinction.
3
Apply Causation: Connect the technology to its causes (scientific research, war, economic incentives) and effects (mortality changes, population growth, inequality).
4
Consider Limitations: Every advance has a "but." Ask: Who was excluded? What unintended consequences emerged?
5
Use Specific Evidence: Name dates, people, organizations (WHO, UN), or specific diseases to strengthen your argument.

Case Study: Smallpox Eradication

Smallpox Eradicated 1980 Vaccine Technology (Jenner+) WHO Global Campaign Cold War Cooperation Millions of Lives Saved Model for Future Campaigns Proved Global Cooperation CAUSES EFFECTS

Case Study: HIV/AIDS Pandemic

Deaths (millions/yr) 1985 1995 2005 2015 2023 0 0.5 1.0 1.5 2.0 ARVs Available (2001) Peak: ~1.9M deaths

Case Study: COVID-19 & Vaccine Inequality

High-Income Nations ~75% Vaccinated By mid-2021 Pre-purchased billions of vaccine doses Rapid mRNA development Low-Income Nations ~10% Vaccinated By mid-2021 Dependent on COVAX donations & aid Cold storage challenges vs.

International Organizations & Disease

WHO (1948)
Coordinated global campaigns: smallpox eradication, polio, malaria. Set international health standards and disease surveillance.
PEPFAR (2003)
U.S. program that provided antiretroviral drugs to millions in Africa. Saved an estimated 25 million lives by 2023.
Gates Foundation
Private philanthropy targeting malaria, tuberculosis, and polio. Raised questions about non-state actors shaping global health policy.

The Antibiotic Resistance Crisis

Antibiotics Introduced Overuse & Misuse Resistant Bacteria Emerge New Antibiotics Developed (slowly) Cycle accelerating since the 1990s ★ 1.27 million deaths from resistant bacteria (2019)

Common Mistakes on the AP Exam

✕ Only Discussing Advances
Many students list medical breakthroughs without addressing who was excluded from their benefits. Always include limitations.
✕ Treating Disease as Isolated
Disease connects to economics, colonialism, and politics. Never discuss it in a vacuum: link it to broader historical processes.
✕ Ignoring Continuity
The AP exam rewards students who show how patterns repeat. HIV/AIDS and COVID-19 both show the same inequality pattern as earlier pandemics.

Advances vs. Limitations Summary

Category Advance Limitation
Antibiotics Cured bacterial infections Antibiotic resistance; unequal access
Vaccines Eradicated smallpox; near-eliminated polio Patent costs; cold storage; vaccine hesitancy
Public Health Clean water, sanitation in Global North Global South lacked infrastructure
HIV/AIDS Drugs ARVs made HIV manageable Took years to reach Sub-Saharan Africa
COVID Vaccines mRNA vaccines developed in under a year Wealthy nations hoarded early supply

Question 1 of 5

The epidemiological transition refers to a shift from:

Question 2 of 5

Which factor was most critical to the successful eradication of smallpox by 1980?

Question 3 of 5

The two historians would most likely agree that:

Question 4 of 5

The global response to COVID-19 vaccine distribution most closely parallels which earlier historical pattern?

Question 5 of 5

Antibiotic resistance is best understood as an example of: